Department of Psychiatry, University of Wisconsin School of Medicine and Public Health, 6001 Research Park Blvd, Milwaukee, WI, 53719, USA.
Masonic Cancer Center, University of Minnesota, 420 Delaware Street SE Minneapolis, Minneapolis, MN, 55455, USA.
J Cancer Surviv. 2023 Jun;17(3):646-656. doi: 10.1007/s11764-023-01354-9. Epub 2023 Mar 14.
Chronic graft-versus-host disease (cGVHD) is a common late complication of allogeneic hematopoietic cell transplantation (HCT). This study comprehensively evaluated physical and psychological function among individuals with cGVHD. Additional aims were to investigate relationships between disease severity and psychological and physical function, and to investigate patterns of psychological and physical function by disease site.
Adults at least 6 months post allogeneic HCT were enrolled and either had cGVHD (n =59) or served as a reference sample of HCT survivors with no cGVHD history (n = 19). Participants completed self-report measures of depression, anxiety, fatigue, insomnia, pain, cognition, and sexual function and had a comprehensive clinical evaluation of cGVHD using NIH consensus scoring criteria. Participants with cGVHD were stratified by disease severity and site and compared to the reference group with no cGVHD.
Participants with mild cGVHD had comparable psychological and physical symptoms to the reference sample, while participants with moderate cGVHD experienced more severe anxiety and problems with sexual function, and participants with severe cGVHD experienced more severe depressive symptoms and pain compared to the reference sample. Participants with cGVHD manifesting in the skin and GI tract had the most severe symptoms, including mood disturbance, fatigue, and pain.
Results suggest that patients with more severe cGVHD and those with cGVHD manifesting in the skin, GI tract, and lungs are at risk for poorer psychological and physical outcomes and may benefit from proactive interventions to optimize function.
慢性移植物抗宿主病(cGVHD)是异基因造血细胞移植(HCT)的常见晚期并发症。本研究全面评估了患有 cGVHD 的个体的身体和心理功能。此外,还旨在研究疾病严重程度与心理和身体功能之间的关系,并通过疾病部位研究心理和身体功能的模式。
至少在异基因 HCT 后 6 个月入组的成年人,患有 cGVHD(n=59)或作为无 cGVHD 病史的 HCT 幸存者参考样本(n=19)。参与者完成了抑郁、焦虑、疲劳、失眠、疼痛、认知和性功能的自我报告量表评估,并使用 NIH 共识评分标准对 cGVHD 进行了全面的临床评估。根据疾病严重程度和部位对患有 cGVHD 的参与者进行分层,并与无 cGVHD 的参考组进行比较。
患有轻度 cGVHD 的参与者的心理和身体症状与参考样本相当,而患有中度 cGVHD 的参与者则经历了更严重的焦虑和性功能问题,患有重度 cGVHD 的参与者则与参考样本相比,表现出更严重的抑郁症状和疼痛。cGVHD 表现在皮肤和胃肠道的参与者症状最严重,包括情绪障碍、疲劳和疼痛。
结果表明,疾病严重程度较高的患者以及 cGVHD 表现在皮肤、胃肠道和肺部的患者,其心理和身体结果较差的风险更高,可能需要积极的干预措施来优化功能。